139 related articles for article (PubMed ID: 9834001)
1. Effects of cholecystokinin octapeptide on a pancreatic acinar carcinoma in the rat.
Hajri A; Damgé C
Pharm Res; 1998 Nov; 15(11):1767-74. PubMed ID: 9834001
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of growth of a transplanted rat pancreatic acinar carcinoma with CCK-8.
Karsenty L; Hajri A; Aprahamian M; Garaud JC; Doffoël M; Damgé C
Pancreas; 1993 Mar; 8(2):204-11. PubMed ID: 8460096
[TBL] [Abstract][Full Text] [Related]
3. Autoradiographic localization of cholecystokinin (CCK) receptor expression during the development of azaserine-induced rat pancreatic carcinoma.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
Pancreas; 1996 Nov; 13(4):401-6. PubMed ID: 8899801
[TBL] [Abstract][Full Text] [Related]
4. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of cholecystokinin receptors in azaserine-induced neoplasms of the rat pancreas.
Bell RH; Kuhlmann ET; Jensen RT; Longnecker DS
Cancer Res; 1992 Jun; 52(12):3295-9. PubMed ID: 1596887
[TBL] [Abstract][Full Text] [Related]
7. Novel expression of gastrin (cholecystokinin-B) receptors in azaserine-induced rat pancreatic carcinoma: receptor determination and characterization.
Zhou W; Povoski SP; Longnecker DS; Bell RH
Cancer Res; 1992 Dec; 52(24):6905-11. PubMed ID: 1458479
[TBL] [Abstract][Full Text] [Related]
8. Temporal expression of the gastrin (CCK-B) receptor during azaserine-induced pancreatic carcinogenesis.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Pancreas; 1993 Sep; 8(5):615-21. PubMed ID: 8302799
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of pancreatic growth by cholecystokinin is mediated by high affinity receptors on rat pancreatic acinar cells.
Dawra R; Saluja A; Lerch MM; Saluja M; Logsdon C; Steer M
Biochem Biophys Res Commun; 1993 Jun; 193(3):814-20. PubMed ID: 8323557
[TBL] [Abstract][Full Text] [Related]
10. Both low- and high-affinity CCK receptor states mediate trophic effects on rat pancreatic acinar cells.
Hoshi H; Logsdon CD
Am J Physiol; 1993 Dec; 265(6 Pt 1):G1177-81. PubMed ID: 8279569
[TBL] [Abstract][Full Text] [Related]
11. Occupation of low-affinity cholecystokinin (CCK) receptors by CCK activates signal transduction and stimulates amylase secretion in pancreatic acinar cells.
Vinayek R; Patto RJ; Menozzi D; Gregory J; Mrozinski JE; Jensen RT; Gardner JD
Biochim Biophys Acta; 1993 Mar; 1176(1-2):183-91. PubMed ID: 7680902
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors.
Zhou W; Povoski SP; Bell RH
J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of messenger RNA for cholecystokinin-A receptor and novel expression of messenger RNA for gastrin (cholecystokinin-B) receptor in azaserine-induced rat pancreatic carcinoma.
Zhou W; Povoski SP; Bell RH
Carcinogenesis; 1993 Oct; 14(10):2189-92. PubMed ID: 8222074
[TBL] [Abstract][Full Text] [Related]
14. Human pancreatic acinar cells do not respond to cholecystokinin.
Ji B; Bi Y; Simeone D; Mortensen RM; Logsdon CD
Pharmacol Toxicol; 2002 Dec; 91(6):327-32. PubMed ID: 12688376
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholecystokinin octapeptide on the exocrine pancreas in a new rat model of type 2 diabetes.
Kuntz E; Pinget M; Damgé C
Eur J Pharmacol; 2002 Jul; 448(2-3):253-61. PubMed ID: 12144949
[TBL] [Abstract][Full Text] [Related]
17. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
Matozaki T; Martinez J; Williams JA
Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032
[TBL] [Abstract][Full Text] [Related]
18. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cholecystokinin receptors in rat pancreas. Evidence for expression of CCK-A receptors but not CCK-B (gastrin) receptors.
Zhou W; Povoski SP; Rosen NA; Longnecker DS; Bell RH
Ann N Y Acad Sci; 1994 Mar; 713():331-3. PubMed ID: 8185179
[No Abstract] [Full Text] [Related]
20. Estradiol alters cholecystokinin stimulus-response coupling in rat pancreatic acini.
Blevins GT; McCullough SS; Wilbert TN; Isom RM; Chowdhury P; Miller ST
Am J Physiol; 1998 Nov; 275(5):G993-8. PubMed ID: 9815029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
